Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity
- PMID: 9385114
Peroxisome proliferator-activated receptor gamma: A key regulator of adipogenesis and systemic insulin sensitivity
Abstract
The adipose cell is now known to play a complex role in energy homeostasis, storing energy and signaling to other tissues concerning the state of energy balance. The past several years have seen an explosive increase in our knowledge of the transcriptional basis of adipocyte differentiation. This review describes the role of peroxisome proliferator-activated receptor gamma in this process, and describes how other transcription factors may affect adipogenesis by modulating PPARgamma amount or activity. Furthermore, PPARgamma and other adipogenic transcription factors provide a focus for beginning to understand how various hormones and metabolites influence the development of this tissue in vivo.
Similar articles
-
Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.Trends Pharmacol Sci. 2004 Jun;25(6):331-6. doi: 10.1016/j.tips.2004.03.012. Trends Pharmacol Sci. 2004. PMID: 15165749 Review.
-
Peroxisome proliferator-activated receptor gamma and the control of adipogenesis.Curr Opin Lipidol. 1997 Aug;8(4):212-8. doi: 10.1097/00041433-199708000-00004. Curr Opin Lipidol. 1997. PMID: 9253537 Review.
-
PPARs and the complex journey to obesity.Nat Med. 2004 Apr;10(4):355-61. doi: 10.1038/nm1025. Nat Med. 2004. PMID: 15057233 Review.
-
Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues.Endocrinology. 2001 Mar;142(3):1269-77. doi: 10.1210/endo.142.3.8037. Endocrinology. 2001. PMID: 11181544
-
[Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].Ann Biol Clin (Paris). 2003 May-Jun;61(3):295-303. Ann Biol Clin (Paris). 2003. PMID: 12805006 Review. French.
Cited by
-
Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.Curr Cardiol Rep. 2002 Nov;4(6):514-21. doi: 10.1007/s11886-002-0116-3. Curr Cardiol Rep. 2002. PMID: 12379175 Review.
-
Conditional disruption of the peroxisome proliferator-activated receptor gamma gene in mice results in lowered expression of ABCA1, ABCG1, and apoE in macrophages and reduced cholesterol efflux.Mol Cell Biol. 2002 Apr;22(8):2607-19. doi: 10.1128/MCB.22.8.2607-2619.2002. Mol Cell Biol. 2002. PMID: 11909955 Free PMC article.
-
PPAR Genomics and Pharmacogenomics: Implications for Cardiovascular Disease.PPAR Res. 2008;2008:374549. doi: 10.1155/2008/374549. PPAR Res. 2008. PMID: 18401448 Free PMC article.
-
Regulation of inflammatory and lipid metabolism genes by eicosapentaenoic acid-rich oil.J Lipid Res. 2012 Aug;53(8):1679-89. doi: 10.1194/jlr.M022657. Epub 2012 May 3. J Lipid Res. 2012. PMID: 22556214 Free PMC article.
-
Multidisciplinary pharmacotherapeutic options for nonalcoholic Fatty liver disease.Int J Hepatol. 2012;2012:950693. doi: 10.1155/2012/950693. Epub 2012 Dec 9. Int J Hepatol. 2012. PMID: 23304532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Miscellaneous